Previous close | 216.90 |
Open | 215.10 |
Bid | 213.00 x N/A |
Ask | 215.00 x N/A |
Day's range | 215.10 - 215.10 |
52-week range | 200.00 - 258.10 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WESTLAKE, Ohio, May 28, 2024--Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion’s 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. The acquisition expands Nordson’s m
WESTLAKE, Ohio, May 20, 2024--Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal second quarter ended April 30, 2024. Sales were $651 million, comparable to the prior year’s second quarter sales of $650 million. The second quarter 2024 sales included a favorable acquisition impact of 5%, partially offset by an organic sales decrease of 4%. The organic sales decrease was driven by ongoing pressure in electronics product lines, partially offset by growth in industrial coating
WESTLAKE, Ohio, May 09, 2024--Nordson Corporation (Nasdaq: NDSN) today announced that its board of directors declared a fiscal year 2024 third quarter cash dividend in the amount of $0.68 per common share, payable on June 4, 2024, to shareholders of record as of the close of business on May 21, 2024.